Resverlogix Corp. (TSE:RVX – Get Free Report) shares passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of C$0.06 and traded as low as C$0.06. Resverlogix shares last traded at C$0.06, with a volume of 1,000 shares traded.
Resverlogix Stock Performance
The stock’s 50-day simple moving average is C$0.06 and its two-hundred day simple moving average is C$0.06. The stock has a market cap of C$15.23 million, a price-to-earnings ratio of -1.10 and a beta of 0.71.
About Resverlogix
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases.
See Also
- Five stocks we like better than Resverlogix
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
